Schedule 13G ownership disclosure
AVADEL PHARMACEUTICALS PLC
Security class unavailable · CUSIP: 05337M104
Event date: 2021-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-22-007083
- Form type
- SC 13G
- Filer
- AVADEL PHARMACEUTICALS PLC
- CIK
- CIK 1012477
- Filed
- Feb 11, 2022
- Reporting period
- Dec 31, 2021
- Description
- Schedule 13G beneficial ownership